Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Multiple Myeloma 14Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2Lymphoma 2Leukemia, Plasma Cell 2Triple Negative Breast Neoplasms 1Smoldering Multiple Myeloma 1Recurrence 1Paraproteinemias 1Neoplasms, Plasma Cell 1Neoplasms 1Immunoglobulin Light-chain Amyloidosis 1Hematologic Diseases 1Hemangioma, Cavernous, Central Nervous System 1Corneal Diseases 1Blood Protein Disorders 1

Interventions

daratumumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Hemangioma, Cavernous, Central Nervous System × daratumumab × Clear all
NCT07026604 2025-06-18

CCM-DS01

Beijing Tiantan Hospital

Phase EARLY_PHASE1 Not yet recruiting
10 enrolled
CNS

Hemangioma, Cavernous, Central Nervous System

Data powered by HemOnc (CC BY 4.0) Colophon âš¡